Recruiting

Longvida Curcumin & Astaxanthin

Sponsor:

Medinutra LLC

Code:

NCT07063056

Conditions

Triglycerides

Eligibility Criteria

Sex: All

Age: 21 - 59

Healthy Volunteers: Accepted

Interventions

Curcumin (Longvida™)

Half Dose Curcumin (Longvida™)

Astaxanthin

Placebo Control

Study Details

Brief summary:

Two dietary supplements are each being compared to a placebo for the ability to help maintain triglycerides in the normal range. The subjects will be adult men and women with moderately high TG values. Serum triglycerides will be measured before and after 6 weeks of taking 1 capsule per day of either Longvida Curcumin, astaxanthin, or a placebo. A few side blood analysis will also be done. These measures are relevant to low level inflammation.

Conditions

Triglycerides

Study ID

NCT07063056

Start date

Jul 18, 2025

Status verified date

Jul, 2026

Completion date

Sep 25, 2026

Anticipated

Primary completion date

Sep 25, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 21 - 59

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Triglyceride reading of 140-250 mg/dL
  • Age 21-59

Exclusion Criteria:

  • Uncontrolled diabetes
  • Hypothyroidism or other hormonal problems that have not stabilized
  • Any liver diseases being actively treated
  • Cancer
  • Renal dialysis use
  • Rheumatoid arthritis and related issues like lupus
  • Inflammatory bowel disease
  • Smoking
  • Low blood pressure
  • Having more than 5 alcoholic drinks per week
  • Extreme obesity (BMI over 37)
  • Pregnancy or lactation

Study Design

Enrollment

64 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Prevention

Interventions and Outcome Measures

Arms

placebo comparator: Control

Subjects will be given 1 capsule per day of a small amount of cellulose

experimental: Regular dose curcumin

Subjects will be given 1 capsule per day of a typical amount of Longvida curcumin (80 mg curcumin)

experimental: Low dose curcumin

Subjects will be given 1 capsule per day of 40 mg curcumin which is half the typical amount of Longvida curcumin

experimental: Astaxanthin

Subjects will be given 1 capsule per day of a typical amount of astaxanthin (12 mg curcumin)

Interventions

Curcumin (Longvida™)

1 capsule per day at a usual curcumin dose for this particular product (80 mg curcumin)

Half Dose Curcumin (Longvida™)

1 capsule per day at half the usual curcumin dose for this particular product (40 mg curcumin as the half dose)

Astaxanthin

1 capsule per day at a usual astaxanthin dose (12 mg)

Placebo Control

Subject will get 1 capsule per day of a small amount of cellulose

Primary outcome measure

  • Trilgycerides [ Time Frame: Pre and post 6 week intervention ]

Central Contacts and Locations

Central contacts

Robert DiSilvestro, Ph.D.

6143489375nutritionstudy111@gmail.com

Locations

Medinutra LLC

Recruiting

Dublin, Ohio, United States, 43016

Contacts

Robert DiSilvestro, Ph.D.

6143489375nutritionstudy111@gmail.com

More Information

Sponsor

Medinutra LLC

Last update posted

Jul 14, 2026

Last verified

Jul, 2026

Keywords

  • Triglycerides
  • Antioxidants
  • Inflammation

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Medinutra LLC on 2026-07-14.